In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 2, 1998, Pages 217-220

  Davey, K G ^a   Johnson, E M ^a   Holmes, A D ^a   Szekely, A ^a   Warnock, D W ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; TRIAZOLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASSAY; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DILUTION; FUNGAL MENINGITIS; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0031873740     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.2.217     Document Type: Article

References (20)

1. Hay, R. J., Mackenzie, D. W. R., Campbell, C. K. & Philpot, C. M. (1980). Cryptococcosis in the United Kingdom and the Irish Republic: an analysis of 69 cases. Journal of Infection 2, 13-22.
2. Dismukes, W. E. (1988). Cryptococcal meningitis in patients with AIDS. Journal of Infectious Diseases 157, 624-8.
3. Powderly, W. G. (1993). Cryptococcal meningitis and AIDS. Clinical Infectious Diseases 17, 837-42.
4. Kovacs, J. A., Kovacs, A. A., Polis, M., Wright, W. C., Gill, V. J., Tuazon, C. U. et al. (1985). Crytococcosis in the acquired immunodeficiency syndrome. Annals of Internal Medicine 103, 533-8.
5. Zuger, A., Louie, E., Holzman, R. S., Simberkoff, M. S. & Rahal, J. J. (1986). Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Annals of Internal Medicine 104, 234-40.
6. Chuck, S. L. & Sande, M. A. (1989). Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. New England Journal of Medicine 321, 794-9.
7. Larsen, R. A., Leal. M. A. E. & Chan, L. S. (1990). Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Annals of Internal Medicine 113, 183-7.
8. Saag, M. S., Powderly, W. G., Cloud, G. A., Robinson, P., Grieco, M. H., Sharkey, P. K. et al. (1992). Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. New England Journal of Medicine 326, 83-9.
9. Powderly, W. G., Saag, M. S., Cloud, G. A., Robinson, P., Meyer, R. D., Jacobson, J. M. et al. (1992). A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. New England Journal of Medicine 326, 793-8.
10. Peetermans, W., Bobbaers, H., Verhaegen, J. & Vandepitte, J. (1993). Fluconazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clinica Belgica 48, 405-9.
11. Paugam, A., Dupouy-Camet, J., Blanche, P., Gangneux, J. P., Tourte-Schaefer, C. & Sicard, D. (1994). Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clinical Infectious Diseases 19, 975-6.
12. Birley, H. D. L., Johnson, E. M., McDonald, P., Parry, C., Carey, P. B. & Warnock, D. W. (1995). Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. International Journal of STD and AIDS 6, 353-5.
13. Currie, B. P., Ghannoum, M., Bessen, L. & Casadevall, A. (1995). Decreased fluconazole susceptibility of a relapse Cryptococcus neoformans isolate after fluconazole treatment. Infectious Diseases in Clinical Practice 4, 318-9.
14. Koletar, S. L., Buesching, W. J. & Fass, R. J. (1995). Emerging resistance to fluconazole among blood and CSF Cryptococcus neoformans isolates. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract E70, p. 98. American Society for Microbiology, Washington, DC.
15. Johnson, E. M., Richardson, M. D. & Warnock, D. W. (1984). In-vitro resistance to imidazole antifungals in Candida albicans. Journal of Antimicrobial Chemotherapy 13, 547-58.
16. National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard. Document M27-A. NCCLS, Wayne, PA.
17. Ghannoum, M. A., Ibrahim, A. S., Fu, Y., Shafiq, M. C., Edwards, J. E. & Criddle, R. S. (1992). Susceptibility testing of Cryptococcus neoformans: a microdilution technique. Journal of Clinical Microbiology 30, 2881-6.
18. Johnson, E. M., Davey, K. G., Szekely, A. & Warnock, D. W. (1995). Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. Journal of Antimicrobial Chemotherapy 36, 787-93.
19. Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. et al. (1997). Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infection. Clinical Infectious Diseases 24, 235-47.
20. Witt, M. D., Lewis, R. J., Larsen, R. A., Milefchik, E. N., Leal, M. A. E., Haubrich, R. H. et al. (1996). Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clinical Infectious Diseases 22, 322-8.